EHCT Stock Overview
European Healthcare Acquisition & Growth Company B.V. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
European Healthcare Acquisition & Growth Company B.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.01 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | -0.065 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| EHCT | NL Capital Markets | NL Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 0.9% |
| 1Y | 0% | 9.1% | 7.6% |
Return vs Industry: EHCT underperformed the Dutch Capital Markets industry which returned 9.1% over the past year.
Return vs Market: EHCT underperformed the Dutch Market which returned 7.6% over the past year.
Price Volatility
| EHCT volatility | |
|---|---|
| EHCT Average Weekly Movement | 0% |
| Capital Markets Industry Average Movement | 3.3% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in NL Market | 7.2% |
| 10% least volatile stocks in NL Market | 2.2% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine EHCT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Thomas Rudolph | www.ehc-company.com |
European Healthcare Acquisition & Growth Company B.V. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or businesses. It focuses on acquiring companies or businesses in the healthcare sector with a focus on biotechnology and specialty pharma, pharma services, medical technology and medical devices, diagnostic and lab services, and bioinformatics, as well as life science tools subsectors in Europe.
European Healthcare Acquisition & Growth Company B.V. Fundamentals Summary
| EHCT fundamental statistics | |
|---|---|
| Market cap | €182.00m |
| Earnings (TTM) | €3.74m |
| Revenue (TTM) | n/a |
48.7x
P/E Ratio0.0x
P/S RatioIs EHCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EHCT income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | -€3.74m |
| Earnings | €3.74m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did EHCT perform over the long term?
See historical performance and comparison